Zhongnan Medical Journal Press

Home Results

A total of 29 result was found. Results that relate to Effectiveness

Efficacy and safety of Tislelizumab combined with chemotherapy in the treatment of non-small cell lung cancer: a Meta-analysis

Published on New Medicine 2025,35(4):442-451.
13301 times 2283 times

WANG Kuan TAN Xiao GUO Yanni

Non-small cell lung cancer Tislelizumab Chemotherapy Effectiveness Safety Meta-analysis
Details
Pharmacoeconomic evaluation of ribociclib plus fulvestrant in second-line treatment of HR+/HER2- advanced breast cancer for postmenopausal women

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):612-620.
12590 times 2109 times

JIA Caifeng WANG Jie ZHANG Sen WANG Meiqi LI Sainan WANG Mingxia

Ribociclib Fulvestrant Advanced breast cancer Postmenopausal Pharmacoeconomic evaluation Cost-effectiveness analysis
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):690-701.
22493 times 2892 times

ZHANG Bin LIU Minna LI Xiaolin LI Jinhu LIU Tianlong

National centralized drug procurement Real world study Clinical evaluation Generic drugs Innovator drugs Effectiveness Safety
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
11263 times 1817 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1057-1065.
16370 times 2224 times

ZHANG Yunxuan ZHOU Haifeng GAO Ningzhou WU Jianbo QIAN Cheng ZHANG Min GUO Han SONG Zhongjuan LIU Xiaoyan

Tirzepatide Type 2 diabetes mellitus Rapid health technology assessment Efficacy Safety Cost-effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1198-1205.
8508 times 1642 times

CHEN Lingbin PAN Weiping CHEN Zhou XU Wentan

Inclisiran Dyslipidemia Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
6426 times 1264 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Application progress of paraben preservatives in pharmaceutical preparations

Published on Frontiers in Pharmaceutical Sciences 2025,29(12):2145-2153.
5809 times 1047 times

YI Qiao WANG Jie YAN Leina

Paraben Antimicrobial effectiveness Safety Methylparaben Ethylparaben Bacteriostat Dosage
Details
Mepolizumab for refractory chronic rhinosinusitis with nasal polyps: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2026,35(2):192-199.
6495 times 1096 times

GU Shilong ZHANG Wenjing GUO Hao

Mepolizumab Refractory chronic rhinosinusitis with nasal polyps Effectiveness safety Cost-effectiveness
Details
Evaluation of the pharmacoeconomics of recombinant human thrombopoietin for the treatment of cancer therapy-induced thrombocytopenia

Published on Chinese Journal of Pharmacoepidemiology 2026,35(4):371-378.
3832 times 992 times

LIANG Hai XIA Runan CHEN Huijuan JIANG Mengyu LI Fanqin YANG Miao MA Jinghe

Recombinant human thrombopoietin Interleukin-11 Cancer Thrombocytopenia Decision tree Cost-effectiveness analysis
Details
Cost-effectiveness analysis of fondaparinux compared with low molecular-weight heparin in the treatment of recurrent spontaneous abortion

Published on Chinese Journal of Pharmacoepidemiology 2026,35(3):281-287.
3792 times 944 times

ZHU Yurong LI Lanlan ZHANG Rui DAI Wei YANG Weihu

Recurrent spontaneous abortion Fondaparinux Low molecular-weight heparin Cost-effectiveness analysis
Details
Cost-effectiveness analysis of sacituzumab tirumotecan versus platinum-based chemotherapy as second-line treatment for progressed EGFR-mutant non-small-cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):553-562.
2818 times 580 times

JIN Lijun ZHANG Lele HAN Lu LYU Zhenye

Sacituzumab tirumotecan Non-small cell lung cancer EGFR mutation Quality adiusted life year Incremental Cost-effectiveness ratio Cost-effectiveness analysis Scenaio analysis
Details
Changes in knowledge, attitudes and practices and analysis of factors influencing the satisfaction of frontline rescue personnel after a health education lecture on post-traumatic stress disorder

Published on New Medicine 2026,36(5):597-604.
1578 times 444 times

WANG Qiao LU Wei GONG Rufang LI Qiongxuan DENG Jiayi PANG Wangying ZHU Meiling DONG Hai-yang SAI Xiaoyong

Frontline rescue personnel Post-traumatic stress disorder Popular science Effectiveness evaluation Survey of current situation
Details
Rapid health technology assessment of donanemab in the treatment of Alzheimer's disease

Published on Chinese Journal of Pharmacoepidemiology 2026,35(7):800-809.
1044 times 308 times

FAN Liming DENG Tiantian LAN Haiyue DONG Yafen QIU Yan WANG Jian

Donanemab Alzheimer's disease Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details